Issues in management: The role of insulin in cardiovascular outcomes

Diabetes/Metabolism Reviews

Volumn 14, Issue SUPPL. 1, 1998, Pages

  Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

CHD; Insulin resistance syndrome; Syndrome X

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYNDROME X;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; RISK FACTORS;

EID: 0031740884     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199809)14:1+3.0.CO;2-Z     Document Type: Conference Paper

References (37)

1. Kannel WB, and McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. JAMA 241: 2035-2038, 1979.
2. Wingard DL, and Barrett-Connor E: Heart disease and diabetes: In Diabetes in America (2nd edn). National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Diabetes Data Group, 1995, pp. 429-448.
3. Diabetes Drafting Group: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers: World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetologia 28: 615-640, 1985.
4. Klein R, Klein BEK, Moss SE, et al.: Glycosylated hemoglobin of diabetic retinopathy. JAMA 260: 2864-2871, 1988.
5. Herman JB, Medalie JH, and Goldbourt U: Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia 13: 229-234, 1977.
6. West KM, Ahuja MMS, Bennett PH, et al: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6: 361-369, 1983.
7. Fuller JH, Shipley MJ, Rose G, et al.: Coronary heart disease and impaired glucose tolerance: the Whitehall Study. Lancet i: 1373-1376, 1980.
8. Morrish NJ, Stevens LK, Head J, et al.: A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics). II. Associated risk factors. Diabetologia 33: 542-548, 1990.
9. Kuusisto J, Mykkänen L, Pyörälä K, and Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-967, 1994.
10. Laakso M, Lehto S, Pentillä I, and Pyörälä K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin dependent diabetes. Circulation 88: 1421-1430, 1993.
11. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1596-1607, 1988.
12. Eschwège E, Richard JL, Thibult N, et al.: Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res (Suppl) 15: 41, 1985.
13. Stern MP: Perspectives in diabetes. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 44: 369-374, 1995.
14. Warram JH, Martin BD, Krolewski AS, Soeldner JS, and Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of Type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915, 1990.
15. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, and Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329: 1988-1992, 1993.
16. Haffner SM, Miettinen H, Gaskill SP, and Stern MP: Decreased insulin secretion and increased insulin secretion are independently related to the 7-year risk of non-insulin dependent diabetes mellitus. Diabetes 44: 1386-1391, 1995.
17. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, and Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet i: 1356-1359, 1989.
18. McPhillips JB, Barrett-Connor E, and Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin dependent diabetes mellitus in a community of older adults. Am J Epidemiol 131: 443-453, 1990.
19. Medalie JH, Papier CM, Goldbourt U, and Herman JB: Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 135: 811-817, 1975.
20. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, and Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263: 2893-2898, 1990.
21. Mykkänen L, Kuusisto J, Pyörälä K, and Laakso M: Cardiovascular disease risk factors as predictors of Type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36: 553-559, 1993.
22. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, and Stern MP: Prospective analyses of the insulin resistance syndrome (Syndrome X). Diabetes 41: 715-722, 1992.
23. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137: 959-965, 1993.
24. Haffner SM, Bowsher RR, Mykkänen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A, and Stern MP: Proinsulin and specific insulin concentrations in high and low risk populations for Type II diabetes. Diabetes 43: 1490-1493, 1994.
25. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, and Reaven GM: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702-706, 1989.
26. Welborn TA, and Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154-160, 1979.
27. Pyörälä K, Savolainen E, Kaukola S, and Haapakoski J: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive during 9-year follow-up of the Helsinki Policeman Study population. Acta Med Scand 701 (Suppl): 38-52, 1985.
28. Després JP, Lamarche B, Mauriége P, Cantin B, Dagenais GR, Moorjani S, and Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957, 1996.
29. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, and Eckfeldt JH: A prospective study for coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 20: 935-942, 1997.
30. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA: Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol 4: 40-45, 1994.
31. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, and Tibblin G: Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 35: 766-770, 1992.
32. Ferrara A, Barrett-Connor EL, and Edelstein SL: Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 140: 857-869, 1994.
33. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, and Karhapää P: Asymptomatic atherosclerosis and insulin resistance. Arteriosclerosis Thromb 11: 1068-1076, 1991.
34. Bressler P, Bailey SR, Matsuda M, and DeFronzo RA: Insulin resistance and coronary artery disease. Diabelologia 39: 1345-1350, 1996.
35. Howard G, O'Leary DH, Zaccaro D, Haffner SM, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, and Bergman R: Insulin sensitivity and atherosclerosis. Circulation 93: 1809-1817, 1996.
36. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, and Bergman RN: Increased insulin resistance and insulin secretion in non-diabetic African Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-748, 1996.
37. Pyörälä K, Pedersen JR, Kjekshus J, Faergerman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20: 614-620, 1997.